Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pharyngitis

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Common Respiratory Disorders

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of depression in patients with oropharyngeal cancer: a systematic review.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2026

Same author

The minimal clinically important difference for the Sniffin' Sticks Identification Test-16 in patients with chronic rhinosinusitis with nasal polyps treated with biologics.

Acta oto-laryngologica·2026

Same author

Plateau in the incidence of oropharyngeal squamous cell carcinoma despite an increasing HPV-positive burden.

European journal of cancer (Oxford, England : 1990)·2026

Same author

[Eosinophilic otitis media].

Ugeskrift for laeger·2026

Same author

[Allergic rhinoconjunctivitis].

Ugeskrift for laeger·2026

Same author

Annual Versus Patient-Initiated Follow-Up in Sleep Apnoea Care: A Quasi-Experimental Study.

Journal of sleep research·2026

Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026

Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026

Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026

Same journal

[Fitness].

Ugeskrift for laeger·2026

Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026

Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 29, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

[Chronic rhinosinusitisand type 2 disease].

Kasper Aanæs¹, Mikkel Christian Alanin¹, Elisabeth Arndal¹

¹Afdeling for Øre-Næse-Halskirurgi og Audiologi, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger

|March 22, 2022

Summary

This summary is machine-generated.

Global airway diseases share inflammatory mechanisms. This review summarizes current treatments for chronic rhinosinusitis (CRS), focusing on type 2 inflammation in CRS with nasal polyps (CRSwNP) and new monoclonal antibody therapies.

More Related Videos

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Published on: June 20, 2018

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Sep 29, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Published on: June 20, 2018

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

Respiratory Medicine
Immunology
Otolaryngology

Background:

Upper and lower airway diseases are often grouped as global airway disease due to shared inflammatory pathways.
Airway comorbidities are frequent, with chronic rhinosinusitis (CRS) affecting 5-12% of the population.
CRS is classified as CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP), differing in inflammatory profiles.

Purpose of the Study:

To review current treatment modalities for global airway diseases, particularly chronic rhinosinusitis.
To highlight the role of type 2 inflammation in CRSwNP and the emergence of new biologic therapies.
To summarize the efficacy of these treatments on symptoms and quality of life.

Main Methods:

Literature review of current treatment strategies for chronic rhinosinusitis.
Focus on inflammatory mechanisms, specifically type 2 inflammation.
Analysis of data regarding monoclonal antibody treatments for severe CRSwNP.

Main Results:

CRSwNP is typically associated with type 2 inflammation, while CRSsNP often involves non-type 2 inflammation.
New monoclonal antibodies targeting type 2 inflammation have shown effectiveness in treating severe, refractory CRSwNP.
These therapies improve nasal polyps, congestion, sense of smell, and overall quality of life.

Conclusions:

Monoclonal antibodies represent a significant advancement in managing severe CRSwNP.
Understanding the distinct inflammatory profiles of CRSsNP and CRSwNP is crucial for targeted treatment.
Further research into airway disease management and novel therapeutic approaches is warranted.